Physician

Bilal Khan Yousufzai, M.D.

According to 2025 Medicare claims, Bilal Yousufzai, M.D. (NPI: 1023458916) practices ophthalmology in the Marietta, GA market, with the plurality of this provider's patient population coming from Cobb, GA. This provider's primary affiliated billing organization is MARIETTA EYE CLINIC, PA (NPI: 1447469507; TIN: 58-1106424) and primary practice location at 30060-1306. Yousufzai is affiliated with the WellStar Clinical Partners Medicare ACO, LLC (ACO ID: A4803), participating under the MSSP model.

Yousufzai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 847 traditional Medicare patients, billed 31,333 HCPCS/CPT codes, and received $1,950,063 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 451 prescription claims across 118 beneficiaries totaling $22,535 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 16 records totaling $505. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $168,431 to $1,950,063. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$975K$2.0M2017 Medicare payment: $168,431 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $931,135 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,319,754 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,212,845 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $777,914 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,009,535 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,625,309 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,950,063 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017120779$168,431
20185104,767$931,135
20197086,461$1,319,754
20205405,783$1,212,845
20214834,036$777,914
20226335,419$1,009,535
202374619,591$1,625,309
202484731,333$1,950,063

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$16K$31K2015 Drug cost: $31,245 (USD; Tot_Drug_Cst)2016 Drug cost: $13,734 (USD; Tot_Drug_Cst)2017 Drug cost: $12,958 (USD; Tot_Drug_Cst)2018 Drug cost: $13,404 (USD; Tot_Drug_Cst)2019 Drug cost: $18,934 (USD; Tot_Drug_Cst)2020 Drug cost: $29,844 (USD; Tot_Drug_Cst)2021 Drug cost: $27,259 (USD; Tot_Drug_Cst)2022 Drug cost: $24,240 (USD; Tot_Drug_Cst)2023 Drug cost: $26,548 (USD; Tot_Drug_Cst)2024 Drug cost: $22,535 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201579383$31,245
201655200$13,734
201746182$12,958
201847144$13,404
201971172$18,934
202089281$29,844
202175210$27,259
202290258$24,240
2023109387$26,548
2024118451$22,535

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg70380$660
67028Injection of drug into eye212835$93
92014Established patient complete exam of visual system7791,677$88
92134Imaging of retina8041,786$30
J2777Injection, faricimab-svoa, 0.1 mg8923,280$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1114,208$5,299
Brimonidine TartrateBrimonidine Tartrate201,073$1,542
Ketorolac TromethamineKetorolac Tromethamine601,792$1,211
DifluprednateDifluprednate16336$930
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat452,544$787

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$505Harrow Eye, LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Bilal Khan Yousufzai, M.D.?

Tedicare shows public-source Medicare data for Bilal Khan Yousufzai, M.D. (NPI 1023458916), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bilal Khan Yousufzai, M.D. have ACO affiliation data?

Bilal Khan Yousufzai, M.D. is shown with ACO affiliation data for WellStar Clinical Partners Medicare ACO, LLC (MSSP, ACO ID A4803).

What billing organization is linked to Bilal Khan Yousufzai, M.D.?

Bilal Khan Yousufzai, M.D. is linked to MARIETTA EYE CLINIC, PA (billing NPI 1447469507) in the available physician profile data.

Does Bilal Khan Yousufzai, M.D. have Open Payments data?

Bilal Khan Yousufzai, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.